Heidi Emilia Saxell

This inventor holds 17 USPTO granted patents, plus 8 CIPO patents and 10 EPO patents, primarily in Crystalline Compounds. Top assignee: Basf Se Corporation. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heidi Emilia Saxell. Retrieved from https://idiyas.com/inventor/heidi-emilia-saxell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 82.4

CIPO Patents = 8

EPO Patents = 10 (Patent Applications = 6)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Ludwigshafen, DE (2012 - 2014)
Carlsburg, DE (2016)
Carlsberg, DE (2011 - 2018)

Company Filing History:

17 out of 5,905

Basf Se Corporation

patents

Years Active: 2011-2018

Loading Chart...

Areas of Expertise:

Fipronil

Saflufenacil

Crystalline Complexes

Hydrates

Aqueous Formulations

Pyrimidinyl Compounds

Pendimethalin

Metazachlor

Dithianon

Trifluoromethyl

Organic Compounds

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9913473 - Crystalline modification of fipronil (2018-03-13),

2. 9451772 - Crystalline modification of fipronil (2016-09-27),

3. 9173391 - Crystalline complexes of 4-hydroxy benzoic acid and selected pesticides (2015-11-03),

4. 8859607 - Crystalline complexes of agriculturally active organic compounds (2014-10-14),

5. 8791046 - Crystalline modification of fipronil (2014-07-29),

6. 8703650 - Liquid suspension concentrate formulations containing saflufenacil (2014-04-22),

7. 8653002 - Aqueous suspension concentrate formulations containing saflufenacil (2014-02-18),

8. 8383664 - Crystalline modification of fipronil (2013-02-26),

9. 8362026 - Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methyl-ethyl)amino]sulfonyl]benzamide (2013-01-29),

10. 8357695 - Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide (2013-01-22),

11. 8324233 - Co-crystals of pyrimethanil and dithianon (2012-12-04),

12. 8309769 - Crystalline forms of 2-[2-chloro-4-methylsulfony1-3-(2,2,2-trifluoroethoxymethyl)benzoyl]cyclohexan-1,3-dione (2012-11-13),

13. 8212054 - Crystalline complexes of pendimethalin and metazachlor (2012-07-03),

14. 8188136 - Crystalline modification of fipronil (2012-05-29),

15. 8101780 - Crystalline form of 3-(difluormethyl)-1-methyl-N-(3',4′,5′-trifluor[1,1′-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide (2012-01-24),

Title: The Innovative Journey of Heidi Emilia Saxell

Introduction: Heidi Emilia Saxell is a pioneering inventor based in Carlsberg, Germany, known for her groundbreaking contributions to the field of innovations and patents.

Latest Patents: Heidi Emilia Saxell holds several patents in various industries, including technology, healthcare, and sustainable energy solutions. Her most recent patents focus on enhancing renewable energy sources and improving healthcare technologies.

Career Highlights: With a career spanning over two decades, Heidi Emilia Saxell has established herself as a leading figure in the world of inventions. Her innovative solutions have not only revolutionized existing technologies but have also paved the way for future advancements in multiple sectors.

Collaborations: Throughout her career, Heidi Emilia Saxell has collaborated with renowned research institutions, universities, and leading companies to bring her inventions to life. Her ability to work across different fields and disciplines has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Heidi Emilia Saxell's relentless pursuit of innovation and her passion for creating solutions to complex challenges have solidified her reputation as a visionary inventor. Her work continues to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.